| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.027 | 0.5 |